Focus on Pharma Episode 15: Straight Talk on FDA's New Process Validation Guidance From Ali Afnan

It will add to the complexity and cost of compliance, in the short term, says one of the guidance's authors, but will offer tremendous savings in the cost of quality, time to market, cost of stockpiled product, and cost of filing process revisions with FDA.